Skip to main content
. 2017 May 22;17:36. doi: 10.1186/s12894-017-0226-2

Fig. 2.

Fig. 2.

Median time to discontinuation for FDC versus concomitant therapy α-blocker plus antimuscarinic. CI: confidence intervals; FDC: fixed-dose combination; HR: hazard ratio; TTD: time to discontinuation